Imagen de Portada

The carbohydrate insulin model is always correct: a point worth reiterating even when commenting on studies that do not concern it

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	John R. Speakman, Lin Gao, Sumei Hu
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Obesity
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Scarce and unpredictable, yet obesogenic: modeling the impact of food insecurity on adiposity in mice
por: Alessandro Bartolomucci, et al.
Publicado: (2025)

The impact of a low‐carbohydrate (vs. low‐fat) diet on fat mass loss in African American women is modulated by insulin sensitivity
por: Catia Martins, et al.
Publicado: (2025)

Metformin attenuates metabolic insulin sensitivity and insulin‐stimulated carbohydrate oxidation after high‐intensity exercise training in adults at risk for metabolic syndrome
por: Steven K. Malin, et al.
Publicado: (2026)

Association of single‐point insulin sensitivity estimator index (SPISE) with future cardiovascular outcomes in patients with type 2 diabetes
por: Simin Deng, et al.
Publicado: (2024)

No evidence from euglycaemic–hyperinsulinaemic clamp studies for greater insulin sensitivity in adults with type 1 diabetes using insulin pump versus multiple daily insulin injections—Post hoc meta‐analysis
por: Andrzej S. Januszewski, et al.
Publicado: (2025)

Validity of dietary assessment methods compared with doubly labeled water in children: A systematic review and meta‐analysis
por: Sanaz Mehranfar, et al.
Publicado: (2024)

Is severe carbohydrate restriction necessary for appetite suppression? The ASKED randomized controlled trial
por: Jessica A. Roekenes, et al.
Publicado: (2024)

Use of continuous glucose monitoring when initiating glucagon‐like peptide ‐ 1 receptor agonist therapy in insulin‐treated diabetes
por: Irl B. Hirsch, et al.
Publicado: (2024)

Biosimilar insulins: Narrative review of the regulatory framework and registration studies
por: Tim Heise, et al.
Publicado: (2025)

Menopause factors and alterations in gut microbiota and insulin homeostasis: A cross‐sectional analysis of the microbiome and insulin longitudinal evaluation study ( MILES )
por: Vincent J. Maffei, et al.
Publicado: (2025)

CRISPLD2, a novel insulin‐sensitizing adipokine that alters adipocyte size
por: Beth A. Griesel, et al.
Publicado: (2025)

Comparative accuracy of smartphone apps and a generative AI tool for carbohydrate counting: An independent bicentric study
por: Michael Joubert, et al.
Publicado: (2025)

Gut‐derived appetite hormones do not explain energy intake differences in humans following low‐carbohydrate versus low‐fat diets
por: Aaron Hengist, et al.
Publicado: (2024)

Effect of a low‐carbohydrate diet on pain and quality of life in female patients with lipedema: a randomized controlled trial
por: Julianne Lundanes, et al.
Publicado: (2024)

Pharmacokinetics and pharmacodynamics of oral insulin ( ORMD ‐0801) in healthy subjects: A phase I study using hyperinsulinaemic‐euglycaemic clamp
por: Yufei Chen, et al.
Publicado: (2025)

Impact of metabolic and bariatric surgery on weight loss and insulin requirements in type 1 and insulin‐treated type 2 diabetes
por: Kamal Abi Mosleh, et al.
Publicado: (2024)

Sustained caloric restriction potentiates insulin action by activating prostacyclin synthase
por: Carmen Merali, et al.
Publicado: (2024)

Postoperative insulin requirements in surgical patients receiving fully automated insulin delivery in the hospital
por: Gabija Krutkyte, et al.
Publicado: (2025)

Postprandial time in tight range with faster insulin aspart compared with standard insulin aspart in youth with type 1 diabetes using automated insulin delivery
por: Klemen Dovč, et al.
Publicado: (2025)

Should carbohydrate‐modified diets be the first option for weight loss in people with impaired glucose metabolism? A scoping review
por: Katie M. Ellison, et al.
Publicado: (2024)

Altered extracellular matrix dynamics is associated with insulin resistance in adolescent children with obesity
por: Aaron L. Slusher, et al.
Publicado: (2024)

Predictability of genetic risk score for insulin resistance is influenced by both BMI and race
por: Marian L. Yurchishin, et al.
Publicado: (2025)

Obstructive sleep apnea is associated with impaired insulin clearance and hepatic insulin sensitivity in paediatric obesity
por: Giuseppina Rosaria Umano, et al.
Publicado: (2025)

Decoding visceral adipose tissue molecular signatures in obesity and insulin resistance: a multi‐omics approach
por: Dipayan Roy, et al.
Publicado: (2024)

Disentangling the relationship between glucose, insulin and brain health: A UK Biobank study
por: Andrew C. Mason, et al.
Publicado: (2025)

Cost‐utility analysis of once‐weekly insulin icodec and once‐daily insulin glargine in patients with type 2 diabetes receiving basal‐bolus insulin therapy in China
por: Nan Dai, et al.
Publicado: (2024)

Differential weight‐loss responses of APOA2 genotype carriers to low‐carbohydrate and low‐fat diets: the DIETFITS trial
por: Chao‐Qiang Lai, et al.
Publicado: (2025)

An overview of insulin therapy for the non‐specialist
por: Philip D. Home
Publicado: (2025)

Metabolic clearance rate of insulin across the glucose tolerance spectrum by race and ethnicity in youth with obesity
por: Wonhee Cho, et al.
Publicado: (2025)

In‐flight glycaemic control using automated insulin delivery systems: A within‐subject comparative pilot study
por: Renald Meçani, et al.
Publicado: (2025)

Effects of weight loss on testosterone, sex hormone‐binding globulin, adiposity, and insulin sensitivity in women and men
por: Justine M. Mucinski, et al.
Publicado: (2025)

Cost‐utility of once‐weekly insulin icodec versus once‐daily basal insulins for type 2 diabetes in China
por: Xichen Tong, et al.
Publicado: (2026)

Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring
por: Howard Wolpert, et al.
Publicado: (2025)

Performance of an automated insulin‐glucagon delivery system versus automated insulin delivery system during challenging inpatient conditions. A single‐blind randomised controlled crossover trial
por: Ajenthen G. Ranjan, et al.
Publicado: (2026)

Comparable glycemic outcomes with insulin glargine and insulin degludec during exercise in adolescents with type 1 diabetes using a standardized management protocol
por: Ivana Rabbone, et al.
Publicado: (2025)

Faster‐acting insulin aspart versus insulin aspart for adults with type 1 diabetes treated with non‐automated insulin pump and continuous glucose monitoring—A double‐blind randomized controlled crossover trial
por: Ajenthen G. Ranjan, et al.
Publicado: (2025)

ADO09, a co‐formulation of pramlintide and insulin A21G, lowers body weight versus insulin lispro in type 1 diabetes
por: Grit Andersen, et al.
Publicado: (2024)

Body size, insulin sensitivity, metabolic health and risk of cardiovascular disease in Chinese adults: Insights from the China Cardiometabolic Disease and Cancer Cohort (4C) study
por: Chunyan Hu, et al.
Publicado: (2024)

Associations of adiponectin concentrations from birth until late adolescence with insulin resistance
por: Yeran Lee, et al.
Publicado: (2025)

Early subcutaneous basal insulin with intravenous insulin infusion for diabetic ketoacidosis management: A systematic review and meta‐analysis of randomised controlled trials
por: Kitti Thammakosol, et al.
Publicado: (2025)